The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Codeine market was valued at US$ 272.9 million in 2023 and is anticipated to reach US$ 182.8 million by 2030, witnessing a CAGR of -5.5% during the forecast period 2024-2030.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
This report aims to provide a comprehensive presentation of the global market for Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
Report Scope
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Codeine market comprehensively. Regional market sizes, concerning products by Ingredient, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Ingredient, by Application, and by regions.
Market Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Ingredient, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Codeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Ingredient, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The global Codeine market was valued at US$ 272.9 million in 2023 and is anticipated to reach US$ 182.8 million by 2030, witnessing a CAGR of -5.5% during the forecast period 2024-2030.
Market competition is intense. Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. For the major company of Codeine, Taiji and Mallinckrodt accounted for about 16% market share respectively in recent years.
This report aims to provide a comprehensive presentation of the global market for Codeine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine.
Report Scope
The Codeine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Codeine market comprehensively. Regional market sizes, concerning products by Ingredient, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Ingredient, by Application, and by regions.
Market Segmentation
By Company
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Ingredient, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Codeine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Ingredient, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Codeine Market Overview
1.1 Product Overview and Scope of Codeine
1.2 Codeine Segment by Ingredient
1.2.1 Global Codeine Market Value Comparison by Ingredient (2024-2030)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine Segment by Application
1.3.1 Global Codeine Market Value by Application: (2024-2030)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Market Size Estimates and Forecasts
1.4.1 Global Codeine Revenue 2019-2030
1.4.2 Global Codeine Sales 2019-2030
1.4.3 Global Codeine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Codeine Market Competition by Manufacturers
2.1 Global Codeine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Codeine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Codeine Average Price by Manufacturers (2019-2024)
2.4 Global Codeine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Codeine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Codeine, Product Type & Application
2.7 Codeine Market Competitive Situation and Trends
2.7.1 Codeine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Codeine Players Market Share by Revenue
2.7.3 Global Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Codeine Retrospective Market Scenario by Region
3.1 Global Codeine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Codeine Global Codeine Sales by Region: 2019-2030
3.2.1 Global Codeine Sales by Region: 2019-2024
3.2.2 Global Codeine Sales by Region: 2025-2030
3.3 Global Codeine Global Codeine Revenue by Region: 2019-2030
3.3.1 Global Codeine Revenue by Region: 2019-2024
3.3.2 Global Codeine Revenue by Region: 2025-2030
3.4 North America Codeine Market Facts & Figures by Country
3.4.1 North America Codeine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Codeine Sales by Country (2019-2030)
3.4.3 North America Codeine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Codeine Market Facts & Figures by Country
3.5.1 Europe Codeine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Codeine Sales by Country (2019-2030)
3.5.3 Europe Codeine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Codeine Market Facts & Figures by Country
3.6.1 Asia Pacific Codeine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Codeine Sales by Country (2019-2030)
3.6.3 Asia Pacific Codeine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Codeine Market Facts & Figures by Country
3.7.1 Latin America Codeine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Codeine Sales by Country (2019-2030)
3.7.3 Latin America Codeine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Codeine Market Facts & Figures by Country
3.8.1 Middle East and Africa Codeine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Codeine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Codeine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Ingredient
4.1 Global Codeine Sales by Ingredient (2019-2030)
4.1.1 Global Codeine Sales by Ingredient (2019-2024)
4.1.2 Global Codeine Sales by Ingredient (2025-2030)
4.1.3 Global Codeine Sales Market Share by Ingredient (2019-2030)
4.2 Global Codeine Revenue by Ingredient (2019-2030)
4.2.1 Global Codeine Revenue by Ingredient (2019-2024)
4.2.2 Global Codeine Revenue by Ingredient (2025-2030)
4.2.3 Global Codeine Revenue Market Share by Ingredient (2019-2030)
4.3 Global Codeine Price by Ingredient (2019-2030)
5 Segment by Application
5.1 Global Codeine Sales by Application (2019-2030)
5.1.1 Global Codeine Sales by Application (2019-2024)
5.1.2 Global Codeine Sales by Application (2025-2030)
5.1.3 Global Codeine Sales Market Share by Application (2019-2030)
5.2 Global Codeine Revenue by Application (2019-2030)
5.2.1 Global Codeine Revenue by Application (2019-2024)
5.2.2 Global Codeine Revenue by Application (2025-2030)
5.2.3 Global Codeine Revenue Market Share by Application (2019-2030)
5.3 Global Codeine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Corporation Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Taiji Codeine Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Corporation Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mallinckrodt Codeine Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TEVA Codeine Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Codeine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Corporation Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medreich Codeine Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Corporation Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Aventis Codeine Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Codeine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Codeine Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Corporation Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hikma Codeine Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Corporation Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pharmaceutical Associates Codeine Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Codeine Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Codeine Description and Business Overview
6.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Apotex Codeine Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Corporation Information
6.12.2 Mylan Codeine Description and Business Overview
6.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Mylan Codeine Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Corporation Information
6.13.2 Aristo Pharma GmbH Codeine Description and Business Overview
6.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Aristo Pharma GmbH Codeine Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Corporation Information
6.14.2 Lannett Company Codeine Description and Business Overview
6.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lannett Company Codeine Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Corporation Information
6.15.2 Laboratoire Riva Codeine Description and Business Overview
6.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Laboratoire Riva Codeine Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Codeine Industry Chain Analysis
7.2 Codeine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Codeine Production Mode & Process
7.4 Codeine Sales and Marketing
7.4.1 Codeine Sales Channels
7.4.2 Codeine Distributors
7.5 Codeine Customers
8 Codeine Market Dynamics
8.1 Codeine Industry Trends
8.2 Codeine Market Drivers
8.3 Codeine Market Challenges
8.4 Codeine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Codeine Market Value Comparison by Ingredient (2024-2030) & (US$ Million)
Table 2. Global Codeine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Codeine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Codeine Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Codeine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Codeine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Codeine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Codeine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Codeine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Codeine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Codeine, Product Type & Application
Table 12. Global Key Manufacturers of Codeine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Codeine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Codeine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Codeine Sales by Region (2019-2024) & (M Units)
Table 18. Global Codeine Sales Market Share by Region (2019-2024)
Table 19. Global Codeine Sales by Region (2025-2030) & (M Units)
Table 20. Global Codeine Sales Market Share by Region (2025-2030)
Table 21. Global Codeine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Codeine Revenue Market Share by Region (2019-2024)
Table 23. Global Codeine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Codeine Revenue Market Share by Region (2025-2030)
Table 25. North America Codeine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Codeine Sales by Country (2019-2024) & (M Units)
Table 27. North America Codeine Sales by Country (2025-2030) & (M Units)
Table 28. North America Codeine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Codeine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Codeine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Codeine Sales by Country (2019-2024) & (M Units)
Table 32. Europe Codeine Sales by Country (2025-2030) & (M Units)
Table 33. Europe Codeine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Codeine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Codeine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Codeine Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Codeine Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Codeine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Codeine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Codeine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Codeine Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Codeine Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Codeine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Codeine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Codeine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Codeine Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Codeine Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Codeine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Codeine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Codeine Sales (M Units) by Ingredient (2019-2024)
Table 51. Global Codeine Sales (M Units) by Ingredient (2025-2030)
Table 52. Global Codeine Sales Market Share by Ingredient (2019-2024)
Table 53. Global Codeine Sales Market Share by Ingredient (2025-2030)
Table 54. Global Codeine Revenue (US$ Million) by Ingredient (2019-2024)
Table 55. Global Codeine Revenue (US$ Million) by Ingredient (2025-2030)
Table 56. Global Codeine Revenue Market Share by Ingredient (2019-2024)
Table 57. Global Codeine Revenue Market Share by Ingredient (2025-2030)
Table 58. Global Codeine Price (USD/Unit) by Ingredient (2019-2024)
Table 59. Global Codeine Price (USD/Unit) by Ingredient (2025-2030)
Table 60. Global Codeine Sales (M Units) by Application (2019-2024)
Table 61. Global Codeine Sales (M Units) by Application (2025-2030)
Table 62. Global Codeine Sales Market Share by Application (2019-2024)
Table 63. Global Codeine Sales Market Share by Application (2025-2030)
Table 64. Global Codeine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Codeine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Codeine Revenue Market Share by Application (2019-2024)
Table 67. Global Codeine Revenue Market Share by Application (2025-2030)
Table 68. Global Codeine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Codeine Price (USD/Unit) by Application (2025-2030)
Table 70. Taiji Corporation Information
Table 71. Taiji Description and Business Overview
Table 72. Taiji Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Taiji Codeine Product
Table 74. Taiji Recent Developments/Updates
Table 75. Mallinckrodt Corporation Information
Table 76. Mallinckrodt Description and Business Overview
Table 77. Mallinckrodt Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mallinckrodt Codeine Product
Table 79. Mallinckrodt Recent Developments/Updates
Table 80. TEVA Corporation Information
Table 81. TEVA Description and Business Overview
Table 82. TEVA Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. TEVA Codeine Product
Table 84. TEVA Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson Codeine Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Medreich Corporation Information
Table 91. Medreich Description and Business Overview
Table 92. Medreich Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Medreich Codeine Product
Table 94. Medreich Recent Developments/Updates
Table 95. Sanofi Aventis Corporation Information
Table 96. Sanofi Aventis Description and Business Overview
Table 97. Sanofi Aventis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Sanofi Aventis Codeine Product
Table 99. Sanofi Aventis Recent Developments/Updates
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Cipla Codeine Product
Table 104. Cipla Recent Developments/Updates
Table 105. Hikma Corporation Information
Table 106. Hikma Description and Business Overview
Table 107. Hikma Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Hikma Codeine Product
Table 109. Hikma Recent Developments/Updates
Table 110. Pharmaceutical Associates Corporation Information
Table 111. Pharmaceutical Associates Description and Business Overview
Table 112. Pharmaceutical Associates Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Pharmaceutical Associates Codeine Product
Table 114. Pharmaceutical Associates Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Novartis Codeine Product
Table 119. Novartis Recent Developments/Updates
Table 120. Apotex Corporation Information
Table 121. Apotex Description and Business Overview
Table 122. Apotex Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Apotex Codeine Product
Table 124. Apotex Recent Developments/Updates
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Mylan Codeine Product
Table 129. Mylan Recent Developments/Updates
Table 130. Aristo Pharma GmbH Corporation Information
Table 131. Aristo Pharma GmbH Description and Business Overview
Table 132. Aristo Pharma GmbH Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Aristo Pharma GmbH Codeine Product
Table 134. Aristo Pharma GmbH Recent Developments/Updates
Table 135. Lannett Company Corporation Information
Table 136. Lannett Company Description and Business Overview
Table 137. Lannett Company Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Lannett Company Codeine Product
Table 139. Lannett Company Recent Developments/Updates
Table 140. Laboratoire Riva Corporation Information
Table 141. Laboratoire Riva Description and Business Overview
Table 142. Laboratoire Riva Codeine Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Laboratoire Riva Codeine Product
Table 144. Laboratoire Riva Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Codeine Distributors List
Table 148. Codeine Customers List
Table 149. Codeine Market Trends
Table 150. Codeine Market Drivers
Table 151. Codeine Market Challenges
Table 152. Codeine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Codeine
Figure 2. Global Codeine Market Value Comparison by Ingredient (2024-2030) & (US$ Million)
Figure 3. Global Codeine Market Share by Ingredient in 2023 & 2030
Figure 4. Single-ingredient Codeine Product Picture
Figure 5. Multi-ingredient Medications Product Picture
Figure 6. Global Codeine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Codeine Market Share by Application in 2023 & 2030
Figure 8. Narcotic Analgesic
Figure 9. Antitussive
Figure 10. Others
Figure 11. Global Codeine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Codeine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Codeine Sales (2019-2030) & (M Units)
Figure 14. Global Codeine Average Price (USD/Unit) & (2019-2030)
Figure 15. Codeine Report Years Considered
Figure 16. Codeine Sales Share by Manufacturers in 2023
Figure 17. Global Codeine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Codeine Players: Market Share by Revenue in 2023
Figure 19. Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Codeine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Codeine Sales Market Share by Country (2019-2030)
Figure 22. North America Codeine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Codeine Sales Market Share by Country (2019-2030)
Figure 26. Europe Codeine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Codeine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Codeine Revenue Market Share by Region (2019-2030)
Figure 34. China Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Codeine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Codeine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Codeine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Codeine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Codeine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Codeine by Ingredient (2019-2030)
Figure 55. Global Revenue Market Share of Codeine by Ingredient (2019-2030)
Figure 56. Global Codeine Price (USD/Unit) by Ingredient (2019-2030)
Figure 57. Global Sales Market Share of Codeine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Codeine by Application (2019-2030)
Figure 59. Global Codeine Price (USD/Unit) by Application (2019-2030)
Figure 60. Codeine Value Chain
Figure 61. Codeine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
